Reddy, Nalini N. ; Rao, Naren P. ; Venkatasubramanian, Ganesan ; Arasappa, Rashmi ; Behere, Rishikesh V. ; Divakaran, Anjith ; Sivakumar, Palanimuthu T. ; Gangadhar, Bangalore N. (2009) Rimonabant-induced catatonia in schizophrenia: A case report Obesity Research & Clinical Practice, 3 (4). pp. 237-239. ISSN 1871-403X
Full text not available from this repository.
Official URL: http://doi.org/10.1016/j.orcp.2009.04.002
Related URL: http://dx.doi.org/10.1016/j.orcp.2009.04.002
Abstract
Patients with psychiatric illness have higher rates of mortality and medical co-morbidity related to increased rates of diabetes mellitus and cardiovascular disease. Rimonabant, a cannabinoid receptor (CB1) antagonist, is an anti-obesity agent and decreases risk for metabolic syndrome. Though there are reports of rimonabant associated with adverse psychiatric events like depression, rimonabant-induced catatonia is not reported. In this first time report, we describe a patient with schizophrenia developing catatonia possibly due to rimonabant.
| Item Type: | Article |
|---|---|
| Source: | Copyright of this article belongs to Elsevier B.V.. |
| Keywords: | Schizophrenia; Catatonia; Rimonabant; Metabolic Syndrome; Obesity. |
| ID Code: | 119089 |
| Deposited On: | 08 Jun 2021 05:08 |
| Last Modified: | 08 Jun 2021 05:08 |
Repository Staff Only: item control page
